Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial

Journal of the National Cancer Institute

Volumn 88, Issue 17, 1996, Pages 1210-1215

  Dillman, Robert O ^a   Herndon, James ^c   Seagren, Stephen L ^b   Eaton Jr , Walter L ^d   Green, Mark R ^b  

^a HOAG MEMORIAL HOSPITAL PRESBYTERIAN   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; VINBLASTINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

EID: 0029778934     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.17.1210     Document Type: Article

References (31)

1. Dillman RO, Seagren SL, Propert K, Eaton WL, Frey EF, Green MR. Protochemotherapy improves survival in regional non-small cell lung cancer (NSCLC). Proc ASCO 1988;7: 195.
2. Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer [see comment citations in Medline]. N Engl J Med 1990;323: 940-5.
3. Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 1995;87: 198-205.
4. Mountain CF. Assessment of the role of surgery for control of lung cancer. Ann Thorac Surg 1977;24:365-73.
5. Mountain CF. A new international staging system for lung cancer. Chest 1986;89(4 Suppl): 225S-33S.
6. Green MR, Kramar A, Schilsky R, Stoopler M, Zimmer B, Richards F 2d, et al. Platinum-based combination chemotherapy in advanced non-small cell lung cancer: a randomized phase II trial of the Cancer and Leukemia Group B. Med Pediatr Oncol 1990;18:197-202.
7. Perez CA, Pajak TF, Rubin P, Simpson JR, Mohiuddin M, Brady LW, et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group. Cancer 1987;59:1874-81.
8. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Soc 1958;53:457-81.
9. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35: 1-39.
10. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-220.
11. Kreisman H, Lisbona A, Olson L, Propert KJ, Modeas C, Dillman RO, et al. Effect of radiologie stage III substage on nonsurgical therapy of non-small cell lung cancer. Cancer 1993;72:1588-96.
12. Le Chevalier T, Arriagada R, Quoix E, Ruffie P, Martin M, Tarayre M, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients [see comment citation in Medline]. J Natl Cancer Inst 1991;83:417-23.
13. Schaake-Koning C, Maat B, van Houtte P, van den Bogaert W, Dalesio O, Kirkpatrick A, et al. Radiotherapy combined with low-dose cisdiammine dichloroplatinum (II) (CDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLC): a randomized three arm phase II study of the EORTC Lung Cancer and Radiotherapy Cooperative Groups. Int J Radiat Oncol Biol Phys 1990;19:967-72.
14. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised trials. Non-small Cell Lung Cancer Collaborative Group [see comment citation in Medline]. BMJ 1995; 311:899-909.
15. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995 [published erratum appears in CA Cancer J Clin 1995;45:127-8]. CA Cancer J Clin 1995;45:8-30.
16. Roswit B, Patno ME, Rapp R, Veinbergs A, Feder B, Stuhlbarg J, et al. The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo. Radiology 1968;90:688-97.
17. Johnson DH, Einhorn LH, Bartolucci A, Birch R, Omura G, Perez CA, et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer [see comment citations in Medline]. Ann Intern Med 1990; 113:33-8.
18. Dillman RO, Berry C, Ryan KP, Green MR, Seagren SL. Recent outcomes for patients with carcinoma of the lung. Cancer Invest 1991; 9:9-17.
19. Payne DG. Non-small-cell lung cancer: should unresectable stage III patients routinely receive high-dose radiation therapy? J Clin Oncol 1988;6:552-8.
20. Raby B, Pater J, Mackillop WJ. Does knowledge guide practice? Another look at the management of non-small-cell lung cancer. J Clin Oncol 1995;13:1904-11.
21. Hesketh PJ, Gandara DR. Serotonin antagonists: a new class of antiemetic agents. J Natl Cancer Inst 1991;83:613-20.
22. Henry DH, Brooks BJ Jr, Case DC Jr, Fishkin E, Jacobson R, Keller AM, et al. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy. Cancer J Sci Am 1995;1:252-60.
23. Demetri GD, Griffin JD. Granulocyte colony-stimulating factor and its receptor. Blood 1991;78:2791-808.
24. Lilenbaum RC, Green MR. Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer. J Clin Oncol 1993;11: 1391-402.
25. Ihde DC. Chemotherapy of lung cancer. N Engl J Med 1992;327:1434-41.
26. Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB Jr, Lee LS, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer [see comment citation in Medline]. J Natl Cancer Inst 1994;86:673-80.
27. Rosell R, Gomez-Codina J, Camps C, Maestre J, Padille J, Canto A, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer [see comment citations in Medline]. N Engl J Med 1994;330: 153-8.
28. Strauss GM, Herndon JE, Sherman DD, Mathisen DJ, Carey RW, Choi NC, et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 1992;10:1237-44.
29. Weiden PL, Piantadosi S. Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer: a phase II study of the Lung Cancer Study Group. J Natl Cancer Inst 1991;83:266-73.
30. Albain K, Rusch V, Crowley J, Turrisi A, Rice T, Livingston R. Concurrent cisplatin/etoposide (PE) + chest radiation (CRT) followed by surgery for stages 3A(N2) and 3B non-small cell lung cancer: completed analysis of SWOG-8805. Proc ASCO 1994;13;337.
31. Blanke C, Ansari R, Mantravadi R, Gonin R, Tokars R, Fisher W, et al. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer; a Hoosier Oncology Group protocol. J Clin Oncol 1995;13:1425-9.